Search

everythinglearnresearchcommunity

for

Search:↓

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

PCL nanoscaffold-based liver spheroids are effective for drug screening and studying liver toxicity.

New methods improve stem cell delivery for heart disease, but challenges remain.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

New regenerative therapies show promise for treating hair loss.

Vesicle-based therapies from stem cells and plants improve burn healing and could be safe, scalable alternatives to cell transplants.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Skin organoids from stem cells could better mimic real skin but face challenges.

"Clinically proven" claims require strict testing and adherence to guidelines for trust and authenticity.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

The mouse models are effective for testing new hair loss treatments.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Advanced human skin models improve drug development and could replace animal testing.

3D printed alginate-gelatin hydrogels are promising for drug delivery and testing treatments for diseases like Alzheimer's.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Microextraction techniques improve hormone testing while being environmentally friendly.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Bioengineered skin models help reduce animal testing and advance research in cosmetics and skin disease.